Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05794659
Title Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer (Cornerstone4)
Acronym Cornerstone4
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aston Sci. Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.